Methods and compositions for inhibition of angiogenesis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/454 (2006.01)

Patent

CA 2512926

The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis. Importantly, these compounds can be administered orally.

La présente invention porte sur un groupe de composés qui inhibent efficacement l'angiogenèse. De façon plus précise, il a été établi que la thalidomide et divers composés apparentés comme les précurseurs de la thalidomide, des analogues, des métabolites et des produits d'hydrolyse inhibent l'angiogenèse. Plus important encore, ces composés peuvent être administrés par voie orale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods and compositions for inhibition of angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for inhibition of angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for inhibition of angiogenesis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1370121

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.